Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Patterns With Targeted Therapies in Metastatic Renal Cell Carcinoma (mRCC) in Sweden - A Retrospective Analysis of Data From National Registries

NCT04669366 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04669366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04669366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Patterns With Targeted Therapies in Metastatic Renal Cell Carcinoma (mRCC) in Sweden - A Retrospective Analysis of Data From National Registries
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 20, 2021
Completion date
March 18, 2022
Enrollment
1,205 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney neoplasms